Scientific Corner

One day ahead of the EAN Congress 2026 in Geneva, neurologists and researchers from across Europe took part in the annual EAN Guidelines Workshop

Dementia imposes huge cost across 30 high-income European countries, with families and unpaid informal carers carrying much of the burden, according to the COIN-Eu study published in the Journal of Alzheimer’s Disease.

Our summary of neurological news items the European Medicines Agency (EMA) monthly Human Medicines Newsletter.

We are proud to present the second edition of the EAN Panel Yearbook, bringing together the most relevant scientific advances from across the neurological field.

Our summary of neurological news items the European Medicines Agency (EMA) monthly Human Medicines Newsletter.

Scientific Committee Chair, Gereon R. Fink provides news on the EAN Scientific Panels, guideline activity and several ongoing and ending projects.

Two positions available for motivated individuals who wish to contribute to the production of high-quality, evidence-based neurological guidelines.

Our summary of neurological news items the European Medicines Agency (EMA) monthly Human Medicines Newsletter.

A review of the now-completed ENERGY project, established to provide robust epidemiological data on neurological manifestations in patients with COVID-19.

The European Journal of Neurology recognises its most active reviewers of 2025, offering an article processing charge waiver to those who reviewed five or more papers.

The fifth Science School took place in Salzburg, Austria on 13-17 March 2026, bringing together 57 participants from 21 countries.

Join us for an engaging workshop where you will step into the role of a Task Force member working on the development of an EAN clinical guideline!

Emerging research shows that the gut–brain axis plays a crucial role in shaping neuroinflammation, brain resilience, and long‑term neurological health—making daily lifestyle and nutrition choices more important than ever.

A new COIN‑EU publication reveals that sleep disorders—affecting up to 30% of Europeans—carry a far greater health and economic burden than previously recognized, costing nearly €423 billion each year.

A new EAN guideline on the diagnostic approach to oligo/asymptomatic hyperCKemia has been published in the European Journal of Neurology